Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis.

Record Detail

Save:
Title:	Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis.
Author:	Sharquie, K E : Najim, R A : Farjou, I B : Al Timimi, D J
Citation:	Clin-Exp-Dermatol. 2001 Jan; 26(1): 21-6
Abstract:	A clinical trial to evaluate the efficiency of oral zinc sulphate in the treatment of cutaneous leishmaniasis was conducted. One-hundred and four patients with parasitologically proven cutaneous leishmaniasis were included in the trial. Patients were assigned randomly to receive 2.5, 5 or 10 mg/kg of zinc sulphate orally, and a control group of patients did not receive any treatment. All patients were followed up for 45 days. At the end of the follow-up period, lesions were assessed and parasitological proof of cure or otherwise was sought. Results showed that the cure rate for the 2.5 mg/kg group was 83.9%, for the 5 mg/kg treatment group it was 93.1% and for the 10 mg/kg treatment group it was 96.9%. No lesions in the control group showed any sign of healing during the follow-up period. Therefore, oral zinc sulphate can be recommended as a very safe therapy for cutaneous leishmaniasis.
Review References:	None
Notes:	Copyright Blackwell Science Ltd. Hypertext links to electronic journal sites, if available, can be found in the the Peer Reviewed Journal List on the IBIDS home page.
Language:	English
Publication Type:	Clinical-Trial; Journal-Article; Randomized-Controlled-Trial
Keywords:	Astringents administration and dosage : Leishmaniasis, Cutaneous drug therapy : Zinc Sulfate administration and dosage
URL:	http://www.blackwell-science.com/products/journals/ced.htm